Shares of Diploma PLC (LON:DPLM - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 4,299.31 ($58.53) and traded as high as GBX 4,904 ($66.76). Diploma shares last traded at GBX 4,868 ($66.27), with a volume of 407,228 shares traded.
Diploma Trading Up 0.4%
The company has a market cap of £6.52 billion, a P/E ratio of 56.16, a PEG ratio of 2.82 and a beta of 0.75. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17. The business has a fifty day moving average price of GBX 4,377.26 and a 200-day moving average price of GBX 4,299.31.
Diploma (LON:DPLM - Get Free Report) last released its quarterly earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.09) earnings per share (EPS) for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. On average, analysts forecast that Diploma PLC will post 163.7995512 earnings per share for the current year.
Insider Activity
In related news, insider Katie Bickerstaffe purchased 13 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The stock was acquired at an average cost of GBX 4,982 ($67.82) per share, for a total transaction of £647.66 ($881.65). Over the last 90 days, insiders acquired 96 shares of company stock valued at $473,173. 0.52% of the stock is owned by company insiders.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
